Eisai/Biogen Maintain Lead Over Lilly In New Race To Alzheimer’s Approval

Full Approval Filing May Quickly Follow Accelerated US FDA Decision

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.